| 371 |
Development of a novel prodrug of paclitaxel that is cleaved by prostate-specific antigen: an in vitro and in vivo evaluation study |
2010 |
| 372 |
Effect of pan-retinal laser photocoagulation on plasma VEGF, endothelin-1 and nitric oxide in PDR. |
2010 |
| 373 |
Impact of Genetic Engineering on Human Health, Benefits and Risks . |
2010 |
| 374 |
Impact of Genetic Engineering on Human Health, Benefits and Risks . |
2010 |
| 375 |
Impact of Genetic Engineering on Human Health, Benefits and Risks . |
2010 |
| 376 |
Iron Chelation Therapy in Upper Egyptian Transfusion-dependent Pediatric Homozygous beta-Thalassemia Major Impact on Serum L-Carnitine/Free Fatty Acids, Osteoprotegerin/The Soluble Receptor Activator of Nuclear Factor-kappa beta Ligand Systems, and Bone M |
2010 |
| 377 |
Irritable bowel syndrome in Upper Egypt: The role of intestinal parasites and
evidence of Th2 response |
2010 |
| 378 |
Maternal type 2 diabetes risk alleles and intrauterine growth. |
2010 |
| 379 |
Optimization of an Albumin-Binding Prodrug of Doxorubicin That Is Cleaved by Prostate-Specific Antigen |
2010 |
| 380 |
Optimization of an Albumin-Binding Prodrug of Doxorubicin That Is Cleaved by Prostate-Specific Antigen |
2010 |